Frédéric Ducongé

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cerebrospinal Fluid

Gold Nanoparticles

Cognitive Impairment

Top Venues

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Alix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, Luc Bousset, Ronald Melki, Frédéric Ducongé
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic acids research 52 (14) (2024)
Alix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, Luc Bousset, Ronald Melki, Frédéric Ducongé
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic acids research 52 (14) (2024)
Alix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, Luc Bousset, Ronald Melki, Frédéric Ducongé
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic acids research 52 (14) (2024)
Alix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, Luc Bousset, Ronald Melki, Frédéric Ducongé
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies. Nucleic acids research (2024)
Caroline Zutterling, Anne-Laure Todeschini, Deborah Fourmy, Didier Busso, Xavier Veaute, Frédéric Ducongé, Reiner A Veitia
The forkhead DNA-binding domain binds specific G2-rich RNA sequences. Nucleic acids research (2023)
Antonija Hanžek, Frédéric Ducongé, Christian Siatka, Anne-Cécile E Duc
Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine. Cancers 15 (2) (2023)
Antonija Hanžek, Frédéric Ducongé, Christian Siatka, Anne-Cécile E Duc
Identification and Characterization of Aptamers Targeting Ovarian Cancer Biomarker Human Epididymis Protein 4 for the Application in Urine. Cancers 15 (2) (2023)